$0.020.02 -0.00-0.00 |(-1.41-1.41 %)
52W H: 0.1152W L: 0.02Beta: -0.07
About Oncotelic Therapeutics Inc
- Industry: Biotechnology
- Exchange: OTC MARKETS
- Country: US
- Website: https://www.oncotelic.com/
Frequently Asked Questions
What is the 52-week range for OTLC?
The 52-week high is $0.11 and the 52-week low is $0.02.
What is the P/E ratio for OTLC?
The Price to Earnings (P/E) ratio is 0.04.
What is the dividend yield for OTLC?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 139.65%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 155.26%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.13.
Analyst Recommendation Trends
Wall Street analyst consensus for OTLC over the last few months:
2024-06-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2024-05-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2024-04-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2024-03-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-10 | Fein Seymour Howard | +250 | - | - |
| 2026-07-10 | KING STEVEN W | +250 | - | - |
| 2026-07-10 | Saund Saran | +1,500 | - | - |
| 2026-07-10 | Shah Amit B. | +1,500 | - | - |
| 2026-07-10 | Trieu Vuong | +2,000 | - | - |
| 2026-07-10 | MAIDA ANTHONY E III | +1,500 | - | - |
| 2026-07-01 | Trieu Vuong | +240,000 | $0.0431 | $10,344 |
| 2026-06-24 | Trieu Vuong | +115,000 | $0.045 | $5,175 |
| 2026-06-23 | Trieu Vuong | +75,000 | $0.045 | $3,375 |
| 2026-06-22 | Trieu Vuong | +65,000 | $0.045 | $2,925 |
| 2026-06-22 | Shah Amit B. | +20,000 | $0.05 | $1,000 |
| 2026-06-17 | Trieu Vuong | +239,759 | $0.0446 | $10,693 |
| 2026-06-15 | Trieu Vuong | +96,000 | $0.045 | $4,320 |
| 2026-01-22 | Trieu Vuong | +4,426 | - | - |
| 2025-11-17 | Trieu Vuong | +4,065 | - | - |